Crédit Agricole Création (Crédit Agricole Centre-Est)

Investor profile | Builders Republic

Part of Groupe Crédit Agricole (Caisse régionale)

About

Crédit Agricole Création is the venture capital fund of the regional bank Crédit Agricole Centre-Est, which funds it from its own resources with no time limit. Created in 1999 with €10M, it now has a budget of €25M, after a €5M increase in 2024, and has financed over 135 startups in twenty-five years, with more than thirty in an active portfolio. Refocused since 2018 on venture capital, it invests from seed to Series A, with initial check sizes from €200,000 to €500,000 and up to €1.2M per company, conducting four to five deals per year, spread across greentech, health, and digital sectors. Its territory covers the Rhône, Ain, Saône-et-Loire, and the north of Isère, Drôme, and Ardèche, with most deals in the Lyon metropolitan area. The portfolio includes Mablink Bioscience, acquired by Eli Lilly in 2023, Mecaware, Recyc’Elit, Revcoo, Tenacy, 365Talents, Brenus Pharma, and Carthera. For a Lyon-based founder in seed stage, it is a local banking co-investor.

Key facts

Type
Corporate VC
Stages
Seed,Series A
Sectors
Climate/Cleantech/Greentech, Software/SaaS, Vertical SaaS, Cyber & Security, Healthcare, Digital health, Data & Infrastructure, Energy, Agritech, Biotech
Headquarters
France
Offices
Lyon
Geographic focus
France
Founded
1999

Track record

  • Portfolio companies: 30

Notable investments

Mecaware, Recyc'Elit, Tenacy, Amolyt Pharma

Funds by stage

Other funds investing at the same stages, list by list.

Funds by sector

The funds investing in each sector, based on their rounds over the last 36 months.